CRH and fetal growth restriction: The treatment of BeWo cells with exogenous CRH results in the elevation of cellular corticotropin releasing hormone receptor 1 (CRHR1) levels, which are significantly reduced in PE and intrauterine growth restriction (IUGR) (Chen et al., 2013; Karteris et al., 2003).